Thebaine-Derived Buprenorphine 8mg Sublingual Films from Canada
Sublingual films with 8mg buprenorphine, derived from thebaine alkaloid, for opioid use disorder treatment, in measured unit doses for retail. Fits HTS 3004.49.00 as alkaloid derivative transdermal-like system.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Pharmaceuticals Annex IV: patented pharma articles — 100% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Comply with SAMHSA guidelines for opioid substitution therapies
• Validate film uniformity and dissolution for FDA approval